BIOKANGTAI COVID-19 Vaccine Approved for Phase III Clinical Trial in the Philippines

08/02 .2021

BIOKANGTAI COVID-19 Vaccine Approved for Phase III Clinical Trial in the Philippines

BIOKANGTAI COVID-19 Vaccine Approved for Phase III Clinical Trial in the Philippines
Shenzhen Kangtai says vaccine effective against Delta variant

08/04 .2021

Shenzhen Kangtai says vaccine effective against Delta variant

Shenzhen Kangtai says vaccine effective against Delta variant
Recombinant COVID-19 Vaccine (Adenovirus Vector) licensed for manufacturing

09/06 .2021

Recombinant COVID-19 Vaccine (Adenovirus Vector) licensed for manufacturing

Recombinant COVID-19 Vaccine (Adenovirus Vector) licensed for manufacturing
BioKangtai's Adenovirus Vector COVID-19 Vaccine Obtained EUA in Indonesia

11/03 .2021

BioKangtai's Adenovirus Vector COVID-19 Vaccine Obtained EUA in Indonesia

BioKangtai's Adenovirus Vector COVID-19 Vaccine Obtained EUA in Indonesia
China's BioKangtai Begins First Shipment of AstraZeneca's COVID-19 Shot

11/18 .2021

China's BioKangtai Begins First Shipment of AstraZeneca's COVID-19 Shot

China's BioKangtai Begins First Shipment of AstraZeneca's COVID-19 Shot
Kangtai Adenovirus Vector COVID-19 Vaccine (KCONECAVAC) Exported for the First Time

11/19 .2021

Kangtai Adenovirus Vector COVID-19 Vaccine (KCONECAVAC) Exported for the First Time

Kangtai Adenovirus Vector COVID-19 Vaccine (KCONECAVAC) Exported for the First Time
< 1234 >